Profusa Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 82
Employees
  • Latest Deal Type
  • Conv. Debt
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 15

Profusa General Information

Description

Developer of tissue-integrating biosensors designed to assist continuous monitoring of body chemistry The company's sensor measures tissue-oxygen perfusion in the clinical management of chronic wounds and also has a tissue-integrating scaffold, breaking the biocompatibility barrier, optical reader and adaptable form factor for consumer and medical applications, enabling doctors to help patients to improve personal health and manage diseases easily.

Contact Information

Website
www.profusa.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Monitoring Equipment
Primary Office
  • 5959 Horton Street
  • Suite 450
  • Emeryville, CA 94608
  • United States
+1 (415) 000-0000

Profusa Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Profusa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Convertible Debt 11-Sep-2020 $20M 0000 Completed Generating Revenue
8. Debt - PPP 06-Apr-2020 00.00 0000 Completed Generating Revenue
7. Grant 01-Jan-2019 00000 0000 Completed Generating Revenue
6. Later Stage VC (Series C) 14-Aug-2018 0000 0000 00000 Completed Generating Revenue
5. Grant 01-Jan-2018 00.00 0000 Completed Generating Revenue
4. Grant 06-Feb-2017 00.00 0000 Completed Generating Revenue
3. Grant 12-Jul-2016 00.00 0000 Completed Generating Revenue
2. Later Stage VC (Series B) 16-Dec-2015 $13.2M $16M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 05-Sep-2013 $2.75M $2.75M 000.00 Completed Generating Revenue
To view Profusa’s complete valuation and funding history, request access »

Profusa Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C1 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 5,293,175 $0.000100 8% $2.61 $2.61 1x $2.61 13.49%
Series A 4,350,314 $0.000100 8% $1.22 $1.22 1x $1.22 11.09%
To view Profusa’s complete cap table history, request access »

Profusa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of tissue-integrating biosensors designed to assist continuous monitoring of body chemistry The company's sens
Biotechnology
Emeryville, CA
82 As of 2021
0000
000000000. 0 0000

00000000

rud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in r
0000000000 000000000
San Jose, CA
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000

ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offi
0000000000 000000000
Dublin, Ireland
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Profusa Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corventis Formerly VC-backed San Jose, CA 00 000.00 000000&0 000.00
00000 Venture Capital-Backed Dublin, Ireland 00 000.00 0000000000 0 000.00
000000000 Venture Capital-Backed Ramat Gan, Israel 00 000.00 000000 - 000 000.00
000000000 Venture Capital-Backed Cupertino, CA 0 00.00 00000000000 00.00
00000 00000000000 Venture Capital-Backed Seattle, WA 000 000.00 000000&0
You’re viewing 5 of 9 competitors. Get the full list »

Profusa Executive Team (11)

Name Title Board Seat Contact Info
Ben Hwang Ph.D Chairman & Chief Executive Officer
William McMillan Co-Founder, President and Chief Scientific Officer
Natalie Wisniewski Ph.D Co-Founder, Board Member & Chief Technology Officer
Bruce Smith Chief of Staff
Soya Gamsey Ph.D Vice President, Chemistry Development
You’re viewing 5 of 11 executive team members. Get the full list »

Profusa Board Members (7)

Name Representing Role Since
Andrew Ng Ph.D Self Board Member 000 0000
Ben Hwang Ph.D Profusa Chairman & Chief Executive Officer 000 0000
Joan Braddi Self Board Member 000 0000
Karen Liu Ph.D 3E Bioventures Capital Board Member 000 0000
Tom Gutshall CampVentures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Profusa Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Profusa Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wealthing VC Club Venture Capital Minority 000 0000 000000 0
Maxim Ventures Corporate Venture Capital Minority 000 0000 000000 0
Tasly Holding Group Corporation Minority 000 0000 000000 0
VMS Asset Management PE/Buyout Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial